BioDlink International Company Limited (BIODLINK-B) filed its Monthly Return for the period ended 31 May 2026, confirming that its share capital structure remained unchanged during the month.

• Issued Shares and Treasury Shares Total issued ordinary shares stood at 772.79 million, identical to the previous month. No treasury shares were held or cancelled, leaving the overall share count unchanged.

• Public Float Status Management confirmed compliance with the Main Board’s 25 % minimum public-float requirement as at 31 May 2026.

• Share Option Position Under the Pre-IPO Share Option Scheme adopted on 20 February 2013, 20,000 options with an exercise price of US$0.286 (HK$2.2335) per share remained outstanding. No options were granted, exercised, lapsed or cancelled in May; consequently, no new shares were issued and no proceeds were raised.

• Other Equity Instruments The company reported no outstanding warrants, convertibles or other equity arrangements, and recorded no additional movements in issued or treasury shares.

• Regulatory Confirmations The filing, signed by Joint Company Secretary Lui Wing Yat Christopher, attested that all equity-related activities complied with applicable listing rules, corporate laws and regulatory requirements.

Overall, BioDlink’s capital base and shareholding structure were stable in May 2026, with full adherence to Hong Kong Stock Exchange regulations.